140 related articles for article (PubMed ID: 7537364)
1. Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate.
Millot F; Dhondt JL; Mazingue F; Mechinaud F; Ingrand P; Guilhot F
Pediatr Res; 1995 Feb; 37(2):151-4. PubMed ID: 7537364
[TBL] [Abstract][Full Text] [Related]
2. Impairment of cerebral biogenic amine synthesis in a patient receiving high-dose methotrexate.
Millot F; Dhondt JL; Hayte JM; Bauters F
Am J Pediatr Hematol Oncol; 1992 Aug; 14(3):276-8. PubMed ID: 1380777
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid biogenic amine metabolites in children during treatment for acute lymphocytic leukemia.
Silverstein FS; Hutchinson RJ; Johnston MV
Pediatr Res; 1986 Apr; 20(4):285-91. PubMed ID: 2422625
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome.
Zoghbi HY; Milstien S; Butler IJ; Smith EO; Kaufman S; Glaze DG; Percy AK
Ann Neurol; 1989 Jan; 25(1):56-60. PubMed ID: 2913929
[TBL] [Abstract][Full Text] [Related]
5. Effect of age on cerebrospinal fluid levels of metabolites of biopterin and biogenic amines.
Komori H; Matsuishi T; Yamada S; Ueda N; Yamashita Y; Kato H
Acta Paediatr; 1999 Dec; 88(12):1344-7. PubMed ID: 10626519
[TBL] [Abstract][Full Text] [Related]
6. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
Vlacha V; Eliopoulou M; Haidas S; Beratis NG
Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
[TBL] [Abstract][Full Text] [Related]
7. HPLC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterins.
Ormazabal A; García-Cazorla A; Fernández Y; Fernández-Alvarez E; Campistol J; Artuch R
J Neurosci Methods; 2005 Mar; 142(1):153-8. PubMed ID: 15652629
[TBL] [Abstract][Full Text] [Related]
8. Biopterin and neurotransmitter amine metabolism in children with acute lymphoblastic leukemia receiving methotrexate therapy.
Pinkerton CR; Smith I; Leeming RJ; Sarna G; Hyland K; Curzon G; Chessells JM
J Pediatr; 1986 Mar; 108(3):470-4. PubMed ID: 2419534
[TBL] [Abstract][Full Text] [Related]
9. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
Cole PD; Beckwith KA; Vijayanathan V; Roychowdhury S; Smith AK; Kamen BA
Pediatr Neurol; 2009 Jan; 40(1):34-41. PubMed ID: 19068252
[TBL] [Abstract][Full Text] [Related]
10. [Early neurotoxicity of high-dose of methotrexate and tetrahydrobiopterin deficiency].
Netter JC; Dhondt JL; Rance F; Petrus M
Arch Fr Pediatr; 1991 Dec; 48(10):719-22. PubMed ID: 1793349
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
[TBL] [Abstract][Full Text] [Related]
12. Elevated biopterin and homovanillic acid levels in cerebrospinal fluid from children with aseptic meningitis.
Komori H; Matsuishi T; Yamada S; Ichikawa K; Amamoto M; Yamashita F
J Child Neurol; 1994 Jan; 9(1):22-5. PubMed ID: 8151076
[TBL] [Abstract][Full Text] [Related]
13. [High-dose methotrexate and hyperphenylalaninemia].
Dhondt JL; Farriaux JP; Millot F; Taret S; Hayte JM; Mazingue F
Arch Fr Pediatr; 1991 Apr; 48(4):249-51. PubMed ID: 2069475
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
Locasciulli A; Mura R; Fraschini D; Gornati G; Scovena E; Gervasoni A; Uderzo C; Masera G
Haematologica; 1992; 77(1):49-53. PubMed ID: 1398282
[TBL] [Abstract][Full Text] [Related]
15. Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.
Graham ML; Shuster JJ; Kamen BA; Land VJ; Borowitz MJ; Camitta B; Cheo DL; Harrison MP; Leventhal BG; Pinkel DP; Pullen DJ; Steuber P; Whitehead VM
Clin Cancer Res; 1996 Feb; 2(2):331-7. PubMed ID: 9816176
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
17. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A
Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543
[TBL] [Abstract][Full Text] [Related]
18. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
19. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
Koren G; Ferrazini G; Sulh H; Langevin AM; Kapelushnik J; Klein J; Giesbrecht E; Soldin S; Greenberg M
N Engl J Med; 1990 Jul; 323(1):17-21. PubMed ID: 2355954
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate.
Millot F; Rubie H; Mazingue F; Mechinaud F; Thyss A
Leuk Lymphoma; 1994 Jun; 14(1-2):141-4. PubMed ID: 7920221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
